MedTrace Logo

Recovery of Bupivacaine or Bupivacaine-Lidocaine Spinal Anesthesia and Infiltration Anesthesia in Herniorrhaphy

NCT01548794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2015-04-22

No results posted yet for this study

Summary

The purpose of this study is the investigation of whether adding lidocaine to hyperbaric bupivacaine could decrease the duration of bupivacaine spinal block and provide shorter recovery and discharge times than local infiltration anesthesia in outpatient herniorrhaphy procedures.

Conditions

  • Anesthesia
  • Inguinal Hernia

Interventions

PROCEDURE

spinal anesthesia

To receive 2 ml heavy bupivacaine + 0,6 ml saline

PROCEDURE

spinal anesthesia

To receive 2ml bupivacaine +0,6 ml 1% lidocaine for spinal anesthesia.

PROCEDURE

infiltration anesthesia

To receive step by step local infiltration anesthesia as described by the Lichtenstein Institute.

Sponsors & Collaborators

  • Diskapi Teaching and Research Hospital

    lead OTHER

Principal Investigators

  • Dilek Yazicioglu

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01548794 on ClinicalTrials.gov